Analysts expect Reata Pharmaceuticals, Inc. (NASDAQ:RETA) to report $-1.06 EPS on May, 14.They anticipate $1.21 EPS change or 806.67% from last quarter’s $0.15 EPS. After having $-0.86 EPS previously, Reata Pharmaceuticals, Inc.’s analysts see 23.26% EPS growth. The stock decreased 1.92% or $1.67 during the last trading session, reaching $85.53. About 185,669 shares traded. Reata Pharmaceuticals, Inc. (NASDAQ:RETA) has risen 331.86% since April 14, 2018 and is uptrending. It has outperformed by 327.49% the S&P500. Some Historical RETA News: 11/04/2018 – REATA PHARMACEUTICALS INC RETA.O – BARDOXOLONE CONTINUES TO BE WELL-TOLERATED IN ALPORT SYNDROME PATIENTS; 11/04/2018 – Reata: Bardoxolone Treatment Produced Significant Increase in Kidney Function Maintained Through Week 36; 25/05/2018 – Bardoxolone Methyl Improved Kidney Function in Patients With Autosomal Dominant Polycystic Kidney Disease and lgA Nephropathy in the Ongoing Phase 2 Phoenix Study; 11/04/2018 – Reata Provides Update on the Phase 2 Portion of the CARDINAL Study of Bardoxolone Methyl in Patients With Alport Syndrome; 11/04/2018 – REATA: BARDOXOLONE HAD SIGNIFICANT BOOST IN KIDNEY FUNCTION; 11/04/2018 – REATA PROVIDES UPDATE ON PHASE 2 PORTION OF CARDINAL STUDY; 24/04/2018 – Reata Announces New Preclinical Data Demonstrating the Potential of Omaveloxolone in the Treatment of Friedreich’s Ataxia and Other Severe Neurological Diseases; 16/03/2018 Reata Selected to Present Early-Stage Programs at the BIO Asia International Conference; 22/03/2018 – REATA REPORTS POSITIVE TOP-LINE DATA FOR TREATMENT OF PH-ILD WI; 24/04/2018 – Reata Announces New Preclinical Data Demonstrating the Potential of Omaveloxolone in the Treatment of Friedreich’s Ataxia and
Oreilly Automotive Inc (NASDAQ:ORLY) had an increase of 1.92% in short interest. ORLY’s SI was 1.29 million shares in April as released by FINRA. Its up 1.92% from 1.27 million shares previously. With 951,400 avg volume, 1 days are for Oreilly Automotive Inc (NASDAQ:ORLY)’s short sellers to cover ORLY’s short positions. The SI to Oreilly Automotive Inc’s float is 1.67%. The stock decreased 0.38% or $1.53 during the last trading session, reaching $406.32. About 490,803 shares traded. O'Reilly Automotive, Inc. (NASDAQ:ORLY) has risen 52.30% since April 14, 2018 and is uptrending. It has outperformed by 47.93% the S&P500. Some Historical ORLY News: 09/05/2018 – S&P REVISES O’REILLY AUTOMOTIVE INC. TO RATING ‘BBB’ FROM ‘BBB+’; OUTLOOK ‘STABLE’; 25/04/2018 – O’Reilly Automotive Sees FY18 EPS $15.30-EPS $15.40; 17/04/2018 – O’Reilly Announces Lineup for Eleventh Annual Velocity Conference in San Jose; 22/04/2018 – DJ O’Reilly Automotive Inc, Inst Holders, 1Q 2018 (ORLY); 08/05/2018 – O’REILLY AUTOMOTIVE INC – GREG JOHNSON PROMOTED TO CHIEF EXECUTIVE OFFICER AND CO-PRESIDENT; 14/03/2018 – O’Reilly and NumFOCUS Announce First Jupyter Pop-up in Boston; 20/03/2018 – O’Reilly and Intel Announce Lineup for Artificial Intelligence Conference, New York 2018; 05/04/2018 – O’Reilly’s Secret Harassment Settlements Become Public (Correct); 25/04/2018 – O’Reilly Automotive 1Q EPS $3.61; 25/04/2018 – O’Reilly Auto Closes Above 200-Day Moving Average: Technicals
Investors sentiment increased to 1.01 in 2018 Q4. Its up 0.10, from 0.91 in 2018Q3. It is positive, as 41 investors sold O'Reilly Automotive, Inc. shares while 232 reduced holdings. 88 funds opened positions while 187 raised stakes. 69.48 million shares or 9.76% more from 63.30 million shares in 2018Q3 were reported. Kornitzer Cap Management Ks reported 5,622 shares or 0.04% of all its holdings. 18 were accumulated by Tarbox Family Office. Parkside National Bank & Trust reported 0.01% in O'Reilly Automotive, Inc. (NASDAQ:ORLY). Bancorporation Of America Corporation De stated it has 772,196 shares or 0.05% of all its holdings. Macquarie Group Ltd accumulated 2,000 shares or 0% of the stock. Pacific Glob Mgmt has invested 0.55% in O'Reilly Automotive, Inc. (NASDAQ:ORLY). Beese Fulmer Inv Mngmt, a Ohio-based fund reported 21,372 shares. Rafferty Asset Limited Co holds 0.04% of its portfolio in O'Reilly Automotive, Inc. (NASDAQ:ORLY) for 4,979 shares. Davenport And Lc accumulated 116,610 shares. Comm Comml Bank has 0.1% invested in O'Reilly Automotive, Inc. (NASDAQ:ORLY). Pillar Pacific Capital Management Limited Liability holds 1,020 shares or 0.05% of its portfolio. Decatur holds 18,725 shares. Pinnacle Associate Limited has invested 0.01% in O'Reilly Automotive, Inc. (NASDAQ:ORLY). L S Advsrs Inc invested in 2,744 shares or 0.18% of the stock. Kentucky Retirement has 3,484 shares for 0.13% of their portfolio.
More notable recent O'Reilly Automotive, Inc. (NASDAQ:ORLY) news were published by: Nasdaq.com which released: “3 Retail Stocks to Watch in April – Nasdaq” on April 12, 2019, also Nasdaq.com with their article: “Market Close Report: NASDAQ Composite index closes at 7,637.54 down -5.13 points – Nasdaq” published on March 25, 2019, Nasdaq.com published: “Advance Auto Parts Inc (AAP) Ex-Dividend Date Scheduled for March 21, 2019 – Nasdaq” on March 20, 2019. More interesting news about O'Reilly Automotive, Inc. (NASDAQ:ORLY) were released by: Investorplace.com and their article: “AutoZone Stock Needs Preventative Maintenance, Not More Stock Buybacks – Investorplace.com” published on March 25, 2019 as well as Nasdaq.com‘s news article titled: “Is a Beat Likely for O’Reilly Automotive (ORLY) Q4 Earnings? – Nasdaq” with publication date: February 04, 2019.
Since November 9, 2018, it had 0 insider purchases, and 5 sales for $39.92 million activity. 40,000 O'Reilly Automotive, Inc. (NASDAQ:ORLY) shares with value of $14.88 million were sold by OREILLY DAVID E. HENSLEE GREGORY L sold $18.72 million worth of O'Reilly Automotive, Inc. (NASDAQ:ORLY) on Tuesday, February 12. SHAW JEFF M sold $1.36M worth of stock or 3,615 shares. LAURO JEFFREY ALAN also sold $4.40 million worth of O'Reilly Automotive, Inc. (NASDAQ:ORLY) on Friday, November 9. BURCHFIELD JAY D had sold 1,500 shares worth $563,880.
OÂ’Reilly Automotive, Inc., together with its subsidiaries, engages in the retail of automotive aftermarket parts, tools, supplies, equipment, and accessories in the United States. The company has market cap of $31.85 billion. The firm provides new and remanufactured automotive hard parts, such as alternators, starters, fuel pumps, water pumps, brake system components, batteries, belts, hoses, temperature controls, chassis parts, driveline parts, and engine parts; maintenance items comprising oil, antifreeze products, fluids, filters, wiper blades, lighting products, engine additives, and appearance products; and accessories, such as floor mats, seat covers, and truck accessories. It has a 25.24 P/E ratio. The Company’s stores offer auto body paint and related materials, automotive tools, and professional service well-known provider service equipment.
Among 9 analysts covering O’Reilly Automotive (NASDAQ:ORLY), 6 have Buy rating, 0 Sell and 3 Hold. Therefore 67% are positive. O’Reilly Automotive had 11 analyst reports since October 19, 2018 according to SRatingsIntel. The company was downgraded on Friday, March 1 by Atlantic Securities. The firm has “Strong Buy” rating by Raymond James given on Friday, December 14. As per Friday, October 26, the company rating was maintained by Wells Fargo. The rating was maintained by Jefferies on Friday, October 26 with “Buy”. As per Tuesday, November 6, the company rating was maintained by Morgan Stanley. Citigroup maintained it with “Buy” rating and $454 target in Monday, April 1 report. The firm has “Overweight” rating given on Friday, October 19 by JP Morgan. As per Thursday, October 25, the company rating was maintained by Credit Suisse. The stock of O'Reilly Automotive, Inc. (NASDAQ:ORLY) earned “Buy” rating by J.P. Morgan on Monday, March 25.
More notable recent Reata Pharmaceuticals, Inc. (NASDAQ:RETA) news were published by: Nasdaq.com which released: “Commit To Purchase Reata Pharmaceuticals At $75, Earn 26.7% Annualized Using Options – Nasdaq” on March 27, 2019, also with their article: “Apple Inc. (NASDAQ:AAPL), Boeing Company (The) (NYSE:BA) – China Strength Appears To Give Markets An Early Boost Despite Weak Retail Sales Data – Benzinga” published on April 01, 2019, Nasdaq.com published: “Analysts Estimate Reata Pharmaceuticals, Inc. (RETA) to Report a Decline in Earnings: What to Look Out for – Nasdaq” on February 22, 2019. More interesting news about Reata Pharmaceuticals, Inc. (NASDAQ:RETA) were released by: Seekingalpha.com and their article: “Reata Breaks Out – Seeking Alpha” published on July 25, 2018 as well as Globenewswire.com‘s news article titled: “Reata Pharmaceuticals, Inc. to Report Fourth Quarter and Full Year 2018 Financials and to Provide an Update on Development Programs – GlobeNewswire” with publication date: February 21, 2019.
![](/free-report.png)
Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.